ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BBLGW Bone Biologics Corporation

77.99
0.00 (0.00%)
Jan 30 2025 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 317
Bid Price 3.10
Ask Price 80.00
News -
Share Name Share Symbol Market Stock Type
Bone Biologics Corporation BBLGW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 77.99 16:00:00
Open Price Low Price High Price Close Price Previous Close
79.27 79.27 79.27 77.99 77.99
Trades Shares Traded Average Volume
12 317 -
Last Trade Type Quantity Price Currency
15:00:00 2  80.00 USD

Bone Biologics Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
244.42M 3.13M - 0 -8.95M -2.86 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Bone Biologics

Date Time Source Heading
1/21/202505:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/21/202505:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/13/202416:05Edgar (US Regulatory)Form 8-K - Current report
12/13/202416:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
11/14/202418:19Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain..
11/14/202416:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202410:14Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain..
10/21/202407:05Edgar (US Regulatory)Form 8-K - Current report
10/21/202407:00Business WireBone Biologics Appoints Phillip T. Meikle to its Board of..
10/18/202419:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/18/202419:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
10/04/202416:00Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BBLGW Message Board. Create One! See More Posts on BBLGW Message Board See More Message Board Posts

BBLGW Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has application in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

NASDAQ:BBLGW -

What is the current Bone Biologics Corporation share price?
The current share price of Bone Biologics Corporation is US$ 77.99
How many Bone Biologics Corporation shares are in issue?
Bone Biologics Corporation has 3,134,000 shares in issue
What is the market cap of Bone Biologics Corporation?
The market capitalisation of Bone Biologics Corporation is USD 244.42M
What is the 1 year trading range for Bone Biologics Corporation share price?
Bone Biologics Corporation has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Bone Biologics Corporation?
The price to earnings ratio of Bone Biologics Corporation is -0.39
What is the reporting currency for Bone Biologics Corporation?
Bone Biologics Corporation reports financial results in USD
What is the latest annual profit for Bone Biologics Corporation?
The latest annual profit of Bone Biologics Corporation is USD -8.95M
What is the registered address of Bone Biologics Corporation?
The registered address for Bone Biologics Corporation is 1013 CENTRE ROAD, SUITE 403-B, NEW CASTLE, WILMINGTON, DELAWARE, 19805
What is the Bone Biologics Corporation website address?
The website address for Bone Biologics Corporation is www.bonebiologics.com
Which industry sector does Bone Biologics Corporation operate in?
Bone Biologics Corporation operates in the ORTHO,PROSTH,SURG APPL,SUPLY sector

Your Recent History

Delayed Upgrade Clock